Company / Cash per Share
Foghorn Therapeutics Inc. Cash per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.45
FY2025
5-year range
$1.26 / $2.52
FY2021-FY2025
Trend
+10.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 6 years, ranging from $1.26 in FY2022 to $19.05 in FY2020.
Based on SEC 10-K filings.
1.45 in FY2025 with a 5-year CAGR of -40.2%.
Declined from $1.92 to $1.45 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +4.8%
- 5-Year CAGR
- -40.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 10.9% year-over-year.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.45 | +10.9% |
| FY2024 | $1.31 | -31.8% |
| FY2023 | $1.92 | +52.0% |
| FY2022 | $1.26 | -49.9% |
| FY2021 | $2.52 | -86.8% |
| FY2020 | $19.05 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026